Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1765 Management of MEN1 Related Non-Functioning Pancreatic NETs: A Shifting Paradigm. Results from the Dutch MEN1 Study Group

Introduction: The evidence base when to operate MEN1 related non-functioning pancreatic neuroendocrine tumors (NF-pNETs) is meager.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Nell S

Authors: Nell S, Verkooijen H, Pieterman C, de Herder W, Hermus A,

Keywords: MEN1,

#666 Ability of Tumor Markers for Predicting Future Metastatic Disease in MEN-1 Patients with a Pancreatic Neuroendocrine Tumor

Introduction: The diagnostic value of tumor markers in the follow-up of MEN-1 patients with a pancreatic neuroendocrine tumor (pNET) is unclear.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: De Laat J, Pieterman C, Twisk J, Hermus A, Dekkers O,

Keywords: MEN-1, tumor marker, pNET, SSA,

#664 Natural Course and Survival of Thymic and Bronchopulmonary Neuroendocrine Tumors are Different for Male and Female MEN-1 Patients

Introduction: The course of thymic- and bronchopulmonary neuroendocrine tumors (Th- and Bp-NET) in MEN-1 patients is still unclear.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: De Laat J, Pieterman C, Twisk J, Hermus A, Dekkers O,

Keywords: MEN-1, lung NET, thymic NET, natural course, survival,

#442 Low Diagnostic Accuracy of Tumor Markers for the Annual Screening of Pancreatic Neuroendocrine Tumors in MEN-1 Patients

Introduction: The use of tumor markers for annual screening for pancreatic neuroendocrine tumors (pNET) in Multiple Endocrine Neoplasia type 1 (MEN-1) is debatable because of low-level evidence and high costs.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: De Laat J, Weijmans M, Hermus A, Dekkers O, De Herder W,

Keywords: MEN-1, tumor marker, annual screening, Chromogranin A,